Anatomical Therapeutic Chemical • B01AX07 • caplacizumab

A Alimentary tract and metabolism

B Blood and blood forming organs

B01 Antithrombotic agents

B01A Antithrombotic agents

B01AA Vitamin K antagonists

B01AB Heparin group

B01AC Platelet aggregation inhibitors excl. heparin

B01AD Enzymes

B01AE Direct thrombin inhibitors

B01AF Direct factor xa inhibitors

B01AX Other antithrombotic agents

B01AX01 defibrotide Indicated for: hepatic veno-occlusive disease

B01AX05 fondaparinux sodium Indicated for: prevention and treatment of thromboembolism

B01AX07 caplacizumab Indicated for: acquired thrombotic thrombocytopenic purpura

B02 Antihemorrhagics

B03 Antianemic preparations

B05 Blood substitutes and perfusion solutions

B06 Other hematological agents

C Cardiovascular system

D Dermatologicals

G Genito urinary system and sex hormones

H Systemic hormonal preparations, excluding sex hormones and insulins

J Antiinfectives for systemic use

L Antineoplastic and immunomodulating agents

M Musculo-skeletal system

N Nervous system

P Antiparasitic products, insecticides and repellents

R Respiratory system

S Sensory organs

V Various